Bhanvi Satija / Reuters:
Neuralink says Blindsight, its experimental implant aimed at restoring vision, has received the US FDA's “breakthrough device” designation — Elon Musk's brain-chip startup Neuralink said on Tuesday its implant had received the U.S. Food and Drug Administration's “breakthrough device” designation.
